Related references
Note: Only part of the references are listed.Obesity affects spontaneous pregnancy chances in subfertile, ovulatory women
Jan Willem van der Steeg et al.
HUMAN REPRODUCTION (2008)
Pioglitazone treatment increases whole body fat but not total body water in patients with non-alcoholic steatohepatitis
Bogdan Balas et al.
JOURNAL OF HEPATOLOGY (2007)
Clomiphene, metformin, or both for infertility in the polycystic ovary syndrome
Richard S. Legro et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Drug treatments for obesity: orlistat, sibutramine, and rimonabant
Raj S. Padwal et al.
LANCET (2007)
Effect of overweight and obesity on assisted reproductive technology - a systematic review
A. Maheshwari et al.
HUMAN REPRODUCTION UPDATE (2007)
Glycemic durability of rosiglitazone, metformin, or glyburide monotherapy
Steven E. Kahn et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Pregnancy outcome after first-trimester exposure to metformin: a meta-analysis
Cameron Gilbert et al.
FERTILITY AND STERILITY (2006)
Interpregnancy weight change and risk of adverse pregnancy outcomes: a population-based study
Eduardo Villamor et al.
LANCET (2006)
Metformin versus rosiglitazone in the treatment of polycystic ovary syndrome
A. Mitkov et al.
EUROPEAN JOURNAL OF OBSTETRICS & GYNECOLOGY AND REPRODUCTIVE BIOLOGY (2006)
Combined lifestyle modification and metformin in obese patients with polycystic ovary syndrome. A randomized, placebo-controlled, double-blind multicentre study
T Tang et al.
HUMAN REPRODUCTION (2006)
Randomized trial of lifestyle modification and pharmacotherapy for obesity
TA Wadden et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Prepregnancy obesity and fetal death - A study within the Danish National Birth Cohort
EA Nohr et al.
OBSTETRICS AND GYNECOLOGY (2005)
Metformin and weight loss in obese women with polycystic ovary syndrome: Comparison of doses
LR Harborne et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2005)
Effects of subfertility cause, smoking and body weight on the success rate of IVF
AME Lintsen et al.
HUMAN REPRODUCTION (2005)
Homocysteine levels in women with polycystic ovary syndrome treated with metformin versus rosiglitazone: a randomized study
EB Kilicdag et al.
HUMAN REPRODUCTION (2005)
Responses of serum androgen and insulin resistance to metformin and pioglitazone in obese, insulin-resistant women with polycystic ovary syndrome
C Ortega-González et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2005)
Obesity, obstetric complications and cesarean delivery rate - A population-based screening study
JL Weiss et al.
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY (2004)
Maternal morbid obesity and the risk of adverse pregnancy outcome
MI Cedergren
OBSTETRICS AND GYNECOLOGY (2004)
Effect of flutamide and metformin administered alone or in combination in dieting obese women with polycystic ovary syndrome
A Gambineri et al.
CLINICAL ENDOCRINOLOGY (2004)
Weight change and the risk of gestational diabetes in obese women
NL Glazer et al.
EPIDEMIOLOGY (2004)
Metformin treatment before IVF/ICSI in women with polycystic ovary syndrome; a prospective, randomized, double blind study
SB Kjotrod et al.
HUMAN REPRODUCTION (2004)
Descriptive review of the evidence for the use of metformin in polycystic ovary syndrome
L Harborne et al.
LANCET (2003)
Long-term pharmacotherapy for overweight and obesity: a systematic review and meta-analysis of randomized controlled trials
R Padwal et al.
INTERNATIONAL JOURNAL OF OBESITY (2003)
Metformin and FSH for induction of ovulation in women with polycystic ovarian syndrome
V De Leo et al.
HUMAN REPRODUCTION (2002)
Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin
WC Knowler et al.
NEW ENGLAND JOURNAL OF MEDICINE (2002)
Ovarian function and metabolic factors in women with oligomenorrhea treated with metformin in a randomized double blind placebo-controlled trial
R Fleming et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2002)
Maternal obesity and pregnancy outcome: a study of 287 213 pregnancies in London
NJ Sebire et al.
INTERNATIONAL JOURNAL OF OBESITY (2001)
Insulin reduction with metformin increases luteal phase serum glycodelin and insulin-like growth factor-binding protein 1 concentrations and enhances uterine vascularity and blood flow in the polycystic ovary syndrome
DJ Jakubowicz et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2001)
Metformin increases the ovulatory rate and pregnancy rate from clomiphene citrate in patients with polycystic ovary syndrome who are resistant to clomiphene citrate alone
DT Vandermolen et al.
FERTILITY AND STERILITY (2001)
Maternal weight, pregnancy weight gain, and the risk of antepartum stillbirth
O Stephansson et al.
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY (2001)
Body mass and probability of pregnancy during assisted reproduction treatment: retrospective study
JX Wang et al.
BRITISH MEDICAL JOURNAL (2000)
Effect of long-term treatment with metformin added to hypocaloric diet on body composition, fat distribution, and androgen and insulin levels in abdominally obese women with and without the polycystic ovary syndrome
R Pasquali et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2000)
Share Paper
